Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Recurrence 7 Multiple Myeloma 6 Neoplasms 5 Burkitt Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Waldenstrom Macroglobulinemia 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Medulloblastoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Large Granular Lymphocytic 2 Intraocular Lymphoma 2

Interventions

Oncolytic Virotherapy 2 fluoromisonidazole 1 fludarabine 1 aldesleukin 1 adavosertib 1 Radiotherapy, Intensity-Modulated 1 Magnetic Resonance Spectroscopy 1 Luteolin 1 Interleukin-2 1 Fluorodeoxyglucose F18 1 Cyclophosphamide 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma × Cyclophosphamide × Clear all

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡